• Je něco špatně v tomto záznamu ?

Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases

CA. Dehner, J. Torres-Mora, S. Gupta, BR. Kipp, KC. Halling, S. Chen, LM. Warmke, M. Michal, A. Alani, W. Yu, K. Kovacs, F. Obeidin, OH. Iwenofu, S. Satturwar, JM. Meis, AL. Folpe

. 2024 ; 37 (2) : 100400. [pub] 20231201

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007374

Soft tissue sarcomas harboring EWSR1::PATZ1 are a recently recognized entity with variable morphology and a heterogeneous immunohistochemical profile. We studied 17 such tumors. The tumors occurred in 12 men and 5 women (median age, 50 years; range, 15-71 years), involved the thoracoabdominal soft tissues (14 cases; 82%), lower extremities (2 cases; 12%), and tongue (1 case; 6%), and ranged from 0.7 to 11.3 cm (median, 4.7 cm). All but 1 patient received complete surgical resection; 7 were also treated with neoadjuvant chemo/radiotherapy. All cases showed typical features of EWSR1::PATZ1 sarcoma, including uniform round to spindled cells, fibromyxoid matrix, fibrous bands, hyalinized vessels, and pseudoalveolar/microcystic spaces. Unusual features, seen in a subset of cases, included degenerative-appearing nuclear atypia, epithelioid cytomorphology, mature fat, abundant rhabdomyoblasts, high mitotic activity, and foci with increased cellularity and nuclear atypia. Positive immunohistochemical results were desmin (16/17, 94%), MyoD1 (13/14, 93%), myogenin (6/14, 43%), GFAP (10/10, 100%), S100 protein (15/17, 88%), SOX10 (7/13, 54%), keratin (10/17, 59%), CD99 (4/11, 36%), H3K27me3 (retained expression 9/9, 100%), p16 (absent expression 1/4, 25%), and p53 (wild type 3/3, 100%). Fusion events included EWSR1 exon 8::PATZ1 exon 1 (14/17, 82%), EWSR1 exon 9::PATZ1 exon 1 (2/17, 12%), and EWSR1 exon 7::PATZ1 exon 1 (1/17, 6%). No evaluated tumor had alterations of CDKN2A/B and/or TP53, or MDM2 amplification. Clinical follow-up (16 patients: median, 13.5 months; range, 1-77 months) showed distant metastases in 3 patients (1/3 at time of presentation) and no local recurrences. At the time of last follow-up, 14 patients were disease free, 1 was alive with disease, 1 was dead of disease (at 13 months), and 1 had an indeterminant pulmonary nodule. We conclude that the morphologic spectrum of EWSR1::PATZ1 is broader than has been previously appreciated. Although more long-term follow-up is needed, the prognosis of these very rare sarcomas may be more favorable than previously reported.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007374
003      
CZ-PrNML
005      
20240423155915.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.modpat.2023.100400 $2 doi
035    __
$a (PubMed)38043789
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dehner, Carina A $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
245    10
$a Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases / $c CA. Dehner, J. Torres-Mora, S. Gupta, BR. Kipp, KC. Halling, S. Chen, LM. Warmke, M. Michal, A. Alani, W. Yu, K. Kovacs, F. Obeidin, OH. Iwenofu, S. Satturwar, JM. Meis, AL. Folpe
520    9_
$a Soft tissue sarcomas harboring EWSR1::PATZ1 are a recently recognized entity with variable morphology and a heterogeneous immunohistochemical profile. We studied 17 such tumors. The tumors occurred in 12 men and 5 women (median age, 50 years; range, 15-71 years), involved the thoracoabdominal soft tissues (14 cases; 82%), lower extremities (2 cases; 12%), and tongue (1 case; 6%), and ranged from 0.7 to 11.3 cm (median, 4.7 cm). All but 1 patient received complete surgical resection; 7 were also treated with neoadjuvant chemo/radiotherapy. All cases showed typical features of EWSR1::PATZ1 sarcoma, including uniform round to spindled cells, fibromyxoid matrix, fibrous bands, hyalinized vessels, and pseudoalveolar/microcystic spaces. Unusual features, seen in a subset of cases, included degenerative-appearing nuclear atypia, epithelioid cytomorphology, mature fat, abundant rhabdomyoblasts, high mitotic activity, and foci with increased cellularity and nuclear atypia. Positive immunohistochemical results were desmin (16/17, 94%), MyoD1 (13/14, 93%), myogenin (6/14, 43%), GFAP (10/10, 100%), S100 protein (15/17, 88%), SOX10 (7/13, 54%), keratin (10/17, 59%), CD99 (4/11, 36%), H3K27me3 (retained expression 9/9, 100%), p16 (absent expression 1/4, 25%), and p53 (wild type 3/3, 100%). Fusion events included EWSR1 exon 8::PATZ1 exon 1 (14/17, 82%), EWSR1 exon 9::PATZ1 exon 1 (2/17, 12%), and EWSR1 exon 7::PATZ1 exon 1 (1/17, 6%). No evaluated tumor had alterations of CDKN2A/B and/or TP53, or MDM2 amplification. Clinical follow-up (16 patients: median, 13.5 months; range, 1-77 months) showed distant metastases in 3 patients (1/3 at time of presentation) and no local recurrences. At the time of last follow-up, 14 patients were disease free, 1 was alive with disease, 1 was dead of disease (at 13 months), and 1 had an indeterminant pulmonary nodule. We conclude that the morphologic spectrum of EWSR1::PATZ1 is broader than has been previously appreciated. Although more long-term follow-up is needed, the prognosis of these very rare sarcomas may be more favorable than previously reported.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a sarkom $x genetika $x terapie $x patologie $7 D012509
650    _2
$a transkripční faktory $7 D014157
650    _2
$a protein EWS vázající RNA $x genetika $7 D034802
650    _2
$a proteiny S100 $7 D009418
650    12
$a nádory měkkých tkání $x genetika $x terapie $x patologie $7 D012983
650    _2
$a prognóza $7 D011379
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a transkripční faktory Krüppel-like $7 D051741
655    _2
$a časopisecké články $7 D016428
700    1_
$a Torres-Mora, Jorge $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
700    1_
$a Gupta, Sounak $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
700    1_
$a Kipp, Benjamin R $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
700    1_
$a Halling, Kevin C $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
700    1_
$a Chen, Shaoxiong $u Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
700    1_
$a Warmke, Laura M $u Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
700    1_
$a Michal, Michael $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic; Biopticka Laboratory, Ltd, Plzen, Czech Republic
700    1_
$a Alani, Ali $u Department of Pathology, Baylor University Medical Center, Dallas, Texas
700    1_
$a Yu, Wendong $u Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
700    1_
$a Kovacs, Krisztian $u Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin
700    1_
$a Obeidin, Farres $u Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
700    1_
$a Iwenofu, Obiajulu Hans $u Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio
700    1_
$a Satturwar, Swati $u Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio
700    1_
$a Meis, Jeanne M $u Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
700    1_
$a Folpe, Andrew L $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: folpe.andrew@mayo.edu
773    0_
$w MED00003380 $t Modern pathology $x 1530-0285 $g Roč. 37, č. 2 (2024), s. 100400
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38043789 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155911 $b ABA008
999    __
$a ok $b bmc $g 2081382 $s 1217141
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 37 $c 2 $d 100400 $e 20231201 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace